Full Text View
Tabular View
No Study Results Posted
Related Studies
Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients (CHART)
This study is currently recruiting participants.
Verified November 2012 by Questcor Pharmaceuticals, Inc.
Study NCT01386554   Information provided by Questcor Pharmaceuticals, Inc.

First Received on June 29, 2011.   Last Updated on November 19, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Proteinuria
Idiopathic Membranous Nephropathy
Additional conditions recognized in this trial
Glomerulonephritis, Membranous
Kidney Diseases
Nephrotic Syndrome
More general conditions related to this trial
Autoimmune Diseases
Glomerulonephritis
Immune System Diseases
Nephritis
Nephrosis
Signs and Symptoms
Urination Disorders
Urologic Diseases
Urological Manifestations
Interventions listed in this trial
Repository Corticotropin Injection
Placebo
Additional drug interventions recognized in this trial
Adrenocorticotropic Hormone
More general drug interventions related to this trial
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Questcor Pharmaceuticals, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services